Our study identifies O‐GlcNAcylation at Thr83 as a key modification in obesity‐driven tumor progression, facilitating EIF3H recruitment, YAP stabilization, and tumor‐enhancing functions. The gene discussed is EIF3H; the disease is obesity due to melanocortin 4 receptor deficiency.